🔍 Search: biotech

6 results for "biotech"

Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
Top Stories India India
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for p…
Natco Pharma to invest $14 mn in US-based biotechnology firm eGenesis Inc
Business India India
Natco Pharma to invest $14 mn in US-based biotechnology firm eGenesis Inc
In 2024, Natco Pharma had invested $8 million in eGenesis, Inc through preferred stock
As global drug giants grow cautious, can Chinese biotech keep cashing in on out-licensing?
World China China
As global drug giants grow cautious, can Chinese biotech keep cashing in on out-licensing?
Record-breaking cross-border deals helped make some formerly loss-making Chinese biotech companies profitable in the first half of the year, but multi…
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?
Business India India
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?
Symbiotec Pharmalab IPO enters its second day with 80% subscription and a 34% GMP, indicating strong listing expectations. The Rs 1,757 crore issue of…
Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?
Business India India
Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?
Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh share…
Symbiotec Pharmalab raises ₹526 cr from anchor investors; IPO opens Aug 24
Business India India
Symbiotec Pharmalab raises ₹526 cr from anchor investors; IPO opens Aug 24
Pharma and biotech company Symbiotec Pharmalab Ltd on Friday raised Rs 526 crore from anchor investors days before the opening of its initial public o…
📰
Install NewsTRP
Get news updates on your phone!